Seres Therapeutics, Inc. (MCRB)
8.63
-0.42
(-4.64%)
USD |
NASDAQ |
Mar 13, 16:00
8.46
-0.17
(-1.97%)
After-Hours: 20:00
Seres Therapeutics Total Liabilities (Quarterly) : 93.98M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Altimmune, Inc. | 55.04M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 50.30M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 138.19M |
| Shareholders Equity (Quarterly) | 44.22M |
| Debt to Equity Ratio | 1.876 |
| Current Ratio | 2.555 |
| Net Debt Paydown Yield | 1.63% |